← Back to Clinical Trials
Recruiting NCT06891586
Blood Phoenixin-14 Levels and Echocardiographic Findings in Infants of Diabetic Mothers
Trial Parameters
Condition Newborn Morbidity
Sponsor Konya City Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 84
Sex ALL
Min Age 1 Day
Max Age 5 Days
Start Date 2024-09-01
Completion 2025-10-01
All Conditions
Interventions
echocardiographic evaluation and blood phoenixin-14 level
Brief Summary
In this study, the investigators hypothesize that echocardiographic pathologies observed in infants of diabetic mothers are associated with elevated serum phoenixin-14 levels.
Eligibility Criteria
Inclusion Criteria: * Infants of diabetic mothers * Healthy term infants Exclusion Criteria: * Infants whose families did not provide consent * Infants with a syndromic appearance or congenital heart disease
Related Trials
NCT06256406
Effects of Confortable Environment, Kangaroo Care and Music Therapy in Newborns in Neonatal Intensiv
View Trial →
NCT06693817
Advanced Wireless Sensors for Neonatal Care in the Delivery Room
View Trial →
NCT06891586
Blood Phoenixin-14 Levels and Echocardiographic Findings in Infants of Diabetic Mothers
View Trial →